The physiopathological significance of ceruloplasmin. A possible therapeutic approach

G Floris1, R Medda, A Padiglia

  • 1Department of Sciences Applied to Biosystems, University of Cagliari, Cagliari, Italy.

Biochemical Pharmacology
|December 8, 2000
PubMed

Insights

Ceruloplasmin (Cp) plays a key role in iron homeostasis and exhibits enzymatic and nonenzymatic functions. Its unique structure allows it to oxidize non-iron substrates like 6-hydroxydopamine under physiological conditions without toxic byproducts.

Area of Science:

  • Biochemistry
  • Physiology
  • Molecular Biology

Background:

  • Ceruloplasmin (Cp) is a well-known ferroxidase essential for iron homeostasis.
  • Its unique structure as a multicopper oxidase suggests potential roles beyond iron metabolism.
  • Understanding these diverse functions is crucial for comprehending cellular redox balance.

Purpose of the Study:

  • To review and comment on the physiological roles of ceruloplasmin (Cp).
  • To explore the enzymatic and nonenzymatic functions of Cp beyond iron homeostasis.
  • To investigate the physiological relevance of Cp's interaction with non-iron substrates.

Main Methods:

  • Review of existing literature on ceruloplasmin's physiological roles.
  • Analysis of kinetic parameters of Cp-mediated oxidation reactions.
  • Examination of oxidation byproducts, including the case of 6-hydroxydopamine.

Main Results:

  • Ceruloplasmin (Cp) is confirmed to be involved in iron homeostasis.
  • Cp's unique structure enables it to catalyze oxidation of non-iron substrates.
  • The oxidation of 6-hydroxydopamine by Cp occurs under physiological conditions without generating harmful oxygen intermediates.

Conclusions:

  • Ceruloplasmin (Cp) possesses multifaceted physiological roles, extending beyond iron metabolism.
  • Cp's enzymatic and nonenzymatic activities are significant for cellular processes.
  • The oxidation of specific non-iron substrates by Cp, such as 6-hydroxydopamine, is physiologically relevant and occurs safely.

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...